144 related articles for article (PubMed ID: 15044581)
1. The number needed to treat needs an associated odds estimation.
Aino H; Yanagisawa S; Kamae I
J Public Health (Oxf); 2004 Mar; 26(1):84-7. PubMed ID: 15044581
[TBL] [Abstract][Full Text] [Related]
2. Interpretation of absolute measures of disease risk in comparative research.
Replogle WH; Johnson WD
Fam Med; 2007 Jun; 39(6):432-5. PubMed ID: 17549653
[TBL] [Abstract][Full Text] [Related]
3. The number remaining at risk: an adjunct to the number needed to treat.
Massel D; Cruickshank MK
Can J Cardiol; 2002 Mar; 18(3):254-8. PubMed ID: 11907613
[TBL] [Abstract][Full Text] [Related]
4. Number needed to treat: easily understood and intuitively meaningful? Theoretical considerations and a randomized trial.
Kristiansen IS; Gyrd-Hansen D; Nexøe J; Nielsen JB
J Clin Epidemiol; 2002 Sep; 55(9):888-92. PubMed ID: 12393076
[TBL] [Abstract][Full Text] [Related]
5. Evidence-based evaluation of benefits in therapeutic interventions: methodologically controlled and non-randomly assigned reflections on the number needed to treat.
Gensini GF; Conti AA
Ital Heart J; 2003 Feb; 4(2):80-3. PubMed ID: 12762269
[TBL] [Abstract][Full Text] [Related]
6. How effective is that treatment? The number needed to treat.
Deahl ST
Tex Dent J; 2011 Feb; 128(2):211-9. PubMed ID: 21473250
[TBL] [Abstract][Full Text] [Related]
7. Number needed to treat is incorrect without proper time-related considerations.
Suissa D; Brassard P; Smiechowski B; Suissa S
J Clin Epidemiol; 2012 Jan; 65(1):42-6. PubMed ID: 21816576
[TBL] [Abstract][Full Text] [Related]
8. Annualized was found better than absolute risk reduction in the calculation of number needed to treat in chronic conditions.
Mayne TJ; Whalen E; Vu A
J Clin Epidemiol; 2006 Mar; 59(3):217-23. PubMed ID: 16488351
[TBL] [Abstract][Full Text] [Related]
9. Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials.
Hutton JL
Br J Haematol; 2009 Jun; 146(1):27-30. PubMed ID: 19438480
[TBL] [Abstract][Full Text] [Related]
10. When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment.
Sinclair JC; Cook RJ; Guyatt GH; Pauker SG; Cook DJ
J Clin Epidemiol; 2001 Mar; 54(3):253-62. PubMed ID: 11223323
[TBL] [Abstract][Full Text] [Related]
11. Number needed to treat (NNT): estimation of a measure of clinical benefit.
Walter SD
Stat Med; 2001 Dec; 20(24):3947-62. PubMed ID: 11782045
[TBL] [Abstract][Full Text] [Related]
12. The value of the number-needed-to-treat method in antiepileptic drug trials.
Lesaffre E; Boon P; Pledger GW
Epilepsia; 2000 Apr; 41(4):440-6. PubMed ID: 10756410
[TBL] [Abstract][Full Text] [Related]
13. Show me the evidence: using number needed to treat.
Citrome L
South Med J; 2007 Sep; 100(9):881-4. PubMed ID: 17902287
[TBL] [Abstract][Full Text] [Related]
14. Calculating confidence intervals for the number needed to treat.
Bender R
Control Clin Trials; 2001 Apr; 22(2):102-10. PubMed ID: 11306148
[TBL] [Abstract][Full Text] [Related]
15. Using the number needed to treat in clinical practice.
Weeks DL; Noteboom JT
Arch Phys Med Rehabil; 2004 Oct; 85(10):1729-31. PubMed ID: 15468039
[TBL] [Abstract][Full Text] [Related]
16. Concerning: 'The number needed to treat needs an associated odds estimation'.
Alderson P; Deeks JJ
J Public Health (Oxf); 2004 Dec; 26(4):400; author reply 401. PubMed ID: 15598862
[No Abstract] [Full Text] [Related]
17. Evidence-based dermatology: number needed to treat and its relation to other risk measures.
Manriquez JJ; Villouta MF; Williams HC
J Am Acad Dermatol; 2007 Apr; 56(4):664-71. PubMed ID: 17367615
[TBL] [Abstract][Full Text] [Related]
18. Reporting risks and benefits of therapy by use of the concepts of unqualified success and unmitigated failure: applications to highly cited trials in cardiovascular medicine.
Mancini GB; Schulzer M
Circulation; 1999 Jan; 99(3):377-83. PubMed ID: 9918524
[TBL] [Abstract][Full Text] [Related]
19. Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke.
Saver JL
Arch Neurol; 2004 Jul; 61(7):1066-70. PubMed ID: 15262737
[TBL] [Abstract][Full Text] [Related]
20. A novel method for interpreting survival analysis data: description and test on three major clinical trials on cardiovascular prevention.
Mengozzi A; Tricò D; Natali A
Trials; 2020 Jun; 21(1):578. PubMed ID: 32586346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
